Matter Bioworks is a longevity holding company focused on preserving genome integrity

As we age, our genome is constantly being damaged by exogenous and endogenous sources.

 Occasionally errors are missed and incorporated into the DNA in the form of mutations, structural variations, epigenetic drift, and other types of information loss.
 
At Matter, we have assembled a world-class team of scientists and executives to help counter this critical information loss in the genome.

To achieve this, we are focusing on a number of assets that address key stages in the genomic information loss continuum.

Matter Bioworks

Christopher Bradley

Bert Liang

Jan Vijg

Björn Schumacher

Florian Heidel

Alan Forsythe

Claudia Gravekamp

Alex Maslov

Sam Sharifi, PhD

The Scientific and Medical Research team at Matter Bioworks spearheads pioneering studies focused on understanding and mitigating genomic information loss associated with aging. Comprising experts in oncology, gene editing, and therapeutic development, the team deploys cutting-edge research and clinical strategies to preserve genome integrity and enhance longevity.

Scientific and Medical Research

Leadership Team

Scientific and Medical Research

About

Team members

Other teams at Matter Bioworks

Leadership Team